TMOThermo Fisher Scientific
$657.83+37% 1Y
$657.83
$437.9052 weeks$679.96
TMO in its own filings
Nothing in TMO's filing record raises a hard flag: no restatement, late filing, bankruptcy or delisting notice, and no auditor change next to one. That is the common case, not a distinction.
557
Events found in the filings · across 3,003 filings · the record starts in 2000
- Hard flags
- none
Hard flags
- Most recent filing
- Jul 31, 2026
Most recent filing · Form 10-Q
- Record starts
- Jun 14, 2000
Record starts · the earliest filing Ryufin holds for this name
Details›
- Next results filingsame week as a year ago
- expected around Oct 21, 2026
- Security removed from listing or deregistered14 occurrences · usually a matured note or preferred class, not the common shares
- 2026-01-23
- Material impairmenthistorical
- 2007-06-01
- SEC comment-letter activity37 occurrences
- 2025-04-15
SEC EDGAR submissions index and 8-K item codes; 4.02 and 1.03 items are confirmed against the filing text.
What the company said
The company's own words from its current reports to the SEC, newest first
- Jul 23, 2026E-mail: sandy.pound@thermofisher.com.Earnings release · press release
- Apr 23, 2026E-mail: sandy.pound@thermofisher.com.Earnings release · press release
- Feb 12, 2026On February 12, 2026, Thermo Fisher Scientific Inc. (the “Company”) issued $1,000,000,000 aggregate principal amount of 4.215% Senior Notes due 2031 (the “2031 Notes”), $750,000,000 aggregate principal amount of 4.550% Senior Notes due 2033 (the “2033 Notes”), $1,300,000,000 aggregate principal amount of 4.902% Senior …Material agreement entered · Form 8-K
- Jan 29, 2026E-mail: sandy.pound@thermofisher.com.Earnings release · press release
- Jan 12, 2026Lowery have notified Thermo Fisher Scientific Inc. (the “Company”) of their decisions to leave the Company to pursue other opportunities.Director or officer change · Form 8-K
- Dec 1, 2025On December 1, 2025, Thermo Fisher Scientific (Finance I) B.V. (“Thermo Fisher International”), an indirect, wholly-owned finance subsidiary of Thermo Fisher Scientific Inc. (the “Company”), issued €1,000,000,000 aggregate principal amount of Floating Rate Senior Notes due 2027 (the “Floating Rate Notes”) and …Material agreement entered · Form 8-K
- Oct 29, 2025On October 29, 2025, Thermo Fisher Scientific Inc. (“Thermo Fisher”) issued a press release announcing the execution of a definitive agreement to acquire Clario Holdings, Inc. (“Clario”) for approximately $8.875 billion in cash at the closing of the transaction, with an additional $125 million in deferred …Other event · Form 8-K
- Oct 22, 2025E-mail: sandy.pound@thermofisher.com.Earnings release · press release
- Oct 7, 2025On October 7, 2025, Thermo Fisher Scientific Inc. (the “Company”) issued $500,000,000 aggregate principal amount of 4.200% Senior Notes due 2031 (the “2031 Notes”), $750,000,000 aggregate principal amount of 4.473% Senior Notes due 2032 (the “2032 Notes”), $750,000,000 aggregate principal amount of 4.794% Senior Notes …Material agreement entered · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
opening the record…
On our screens:Stocks that buy back more than they dilute
Diagnostics & Research
The closest names by size in the same industry